Kairos Pharma, Ltd. (KAPA)
(Real Time Quote from BATS)
$0.95 USD
-0.02 (-2.34%)
Updated Aug 7, 2025 03:26 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Kairos Pharma, Ltd. has a market cap of $19.90M, which represents its share price of $0.97 multiplied by its outstanding shares number of 20.46M. As a small-cap company, KAPA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
KAPA 0.95 -0.02(-2.34%)
Will KAPA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KAPA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for KAPA
Kairos Pharma management to meet with Maxim
Maxim to Host Meeting on August 6 with Focus on KAPA
Kairos Pharma management to meet with Maxim
12 Health Care Stocks Moving In Wednesday's After-Market Session
CEO.CA's Inside the Boardroom: Kairos Pharma CEO on Phase 2 Safety Data, 165% Stock Move & ...